Prof. Dr. med. Arndt Hartmann

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

Explaining and Evaluating Deep Tissue Classification by Visualizing Activations of Most Relevant Intermediate Layers (2022) Mohammed A, Geppert CI, Hartmann A, Kuritcyn P, Bruns V, Schmid U, Wittenberg T, et al. Journal article Robust Colon Tissue Cartography with Semi-Supervision (2022) Dexl J, Benz M, Kuritcyn P, Wittenberg T, Bruns V, Geppert CI, Hartmann A, et al. Journal article Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting (2022) Erber R, Angeloni M, Stöhr R, Lux MP, Ulbrich-Gebauer D, Pelz E, Bankfalvi A, et al. Journal article Further Evidence of Neuroprotective Effects of Recombinant Human Erythropoietin and Growth Hormone in Hypoxic Brain Injury in Neonatal Mice (2022) Klepper S, Jung S, Dittmann L, Geppert CI, Hartmann A, Beier N, Trollmann R Journal article ATF2 loss promotes tumor invasion in colorectal cancer cells via upregulation of cancer driver TROP2 (2022) Hübner K, Erlenbach-Wünsch K, Prochazka J, Sheraj I, Hampel C, Mrazkova B, Michalcikova T, et al. Journal article Die Akkreditierung in der Pathologie und Neuropathologie in Deutschland: Rahmenbedingungen und Voraussetzungen (2022) Curelea S, Hartmann A, Varnai-Haendel A Journal article Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment (2022) Stübs F, Koch MC, Dietl A, Adler W, Geppert CI, Hartmann A, Knöll A, et al. Journal article Standardized 18F-FDG PET/CT radiomic features provide information on PD-L1 expression status in treatment-naive patients with non-small cell lung cancer (2022) Zhang R, Hohenforst-Schmidt W, Steppert C, Sziklavari Z, Schmidkonz C, Atzinger A, Kuwert T, et al. Journal article Pathologic response after induction chemo-immunotherapy with single or double immune checkpoint inhibition in locally advanced head and neck squamous cell carcinoma (HNSCC): Expansion cohorts of the CheckRad-CD8 trial. (2022) Hecht M, Eckstein M, Kallies A, Klautke G, Illmer T, von der Grün J, Laban S, et al. Conference contribution The Prognostic and Predictive Significance of Tumor-Infiltrating Memory T Cells Is Reversed in High-Risk HNSCC (2022) Hartan R, Schnellhardt S, Büttner-Herold M, Daniel C, Hartmann A, Fietkau R, Distel L Journal article